Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $100000.0.

  • Amylyx Pharmaceuticals' Depreciation & Amortization (CF) fell 5000.0% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $600000.0, marking a year-over-year decrease of 4005.99%. This contributed to the annual value of $900000.0 for FY2024, which is 1818.18% down from last year.
  • Latest data reveals that Amylyx Pharmaceuticals reported Depreciation & Amortization (CF) of $100000.0 as of Q3 2025, which was down 5000.0% from $100000.0 recorded in Q2 2025.
  • Over the past 5 years, Amylyx Pharmaceuticals' Depreciation & Amortization (CF) peaked at $302000.0 during Q3 2023, and registered a low of $10000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $182000.0 (2022), whereas its average is $154052.6.
  • As far as peak fluctuations go, Amylyx Pharmaceuticals' Depreciation & Amortization (CF) surged by 155000.0% in 2022, and later plummeted by 5000.0% in 2025.
  • Over the past 5 years, Amylyx Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $22000.0 in 2021, then skyrocketed by 727.27% to $182000.0 in 2022, then skyrocketed by 65.38% to $301000.0 in 2023, then tumbled by 33.55% to $200000.0 in 2024, then tumbled by 50.0% to $100000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $100000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and $200000.0 in Q1 2025.